CVS PBM to Pay $45 Million in Rebates to State of Illinois
Drug Topics
JULY 30, 2024
CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.
Tue.Jul 30, 2024
266 
CDC will offer seasonal flu shots to farmworkers to lower bird flu risk
STAT
JULY 30, 2024
The Centers for Disease Control and Prevention announced Tuesday that it is funding a $5 million program to vaccinate livestock industry workers against seasonal flu in a bid to reduce the pandemic risk posed by the ongoing H5N1 bird flu outbreak in cattle. The voluntary program, which will be administered by state and local public health workers, is aimed at getting seasonal flu shots into as many people as possible who are working in proximity to animals — poultry, cows, or other livest
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Cinnamon May Reduce Risk of Cardiovascular Disease in Patients with PCOS
Pharmacy Times
JULY 30, 2024
Polycystic ovary syndrome (PCOS) is closely associated with an increased risk of cardiovascular disease.
STAT+: Dental AI startup raises $30 million, including from Mark Zuckerberg’s dad
STAT
JULY 30, 2024
As the AI race in dentistry grows more heated, a startup called Perceptive is aiming to automate each stage of a dental visit, from imaging to treatment recommendations to the actual surgical procedure. The Boston startup, which recently came out of stealth mode, announced on Tuesday that it has received $30 million in funding to work on a dental system that includes a hand-held imaging machine, an AI algorithm to help diagnose and suggest treatment, and a surgical robot to complete the procedur
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Extends Palforzia Approval to Children 1 to 3 Years Old With Peanut Allergy
Pharmacy Times
JULY 30, 2024
The approval marks the first oral immunotherapy treatment to mitigate allergic reactions, including anaphylaxis.
STAT+: Older GLP-1 drug may help protect brains of Alzheimer’s patients, early study suggests
STAT
JULY 30, 2024
A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimer’s disease, supporting the case for further research on the class of medications — originally developed for obesity and diabetes — in neurological diseases. The Phase 2 randomized trial, led by researchers at Imperial College London, tested Novo Nordisk’s liraglutide, the predecessor to Ozempic and Wegovy, in patients with early Alzheimer’s disease over one y
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Wells Fargo faces class action lawsuit over workers’ high drug costs
STAT
JULY 30, 2024
Former employees sued Wells Fargo on Tuesday, alleging the banking giant violated federal law by not diligently monitoring how much it was paying for their prescription drugs, which led to massive overcharges. The class action lawsuit is the second of its kind filed in federal court, further heightening the legal risks for employers that don’t scrutinize how they purchase health and drug benefits for their workers.
Nearly half of beneficiaries don't know the difference between Medicare and MA: survey
Fierce Healthcare
JULY 30, 2024
The U.S. healthcare system remains complex and inaccessible, leaving many seniors feeling uninformed, according to a new survey from digital health company DUOS. | Seniors are growing more comfortable with technology, but many still don't understand key differences between major health programs.
There’s more data for trans people with HIV than any other disease — but it’s still flawed
STAT
JULY 30, 2024
Transgender people are at higher-than-average risk of contracting HIV. And yet, when epidemiologist Diana Tordoff set out to analyze how transmission of the virus might change in the U.S. over the next 10 years with increased testing and preventative PrEP medication, she found there wasn’t enough existing data on trans and nonbinary people to answer the question for those populations.
Ochsner Health going all-in on ambient AI, taps DeepScribe to deploy tech for 4,700 physicians
Fierce Healthcare
JULY 30, 2024
Ochsner Health is going all-in on ambient AI voice technology for its thousands of doctors and has inked an enterprise agreement to roll out DeepScribe's technology across its health system. | Ochsner Health inked an enterprise-wide agreement with DeepScribe to roll out its AI medical scribe across its 46-hospital system for 4,700 providers.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Health care’s ‘Pepsi challenge’: Doctors’ offices are testing AI tools in head-to-head pilots
STAT
JULY 30, 2024
The “Pepsi challenge” of health care, as one health system executive put it, is on. In the race to test generative AI in medicine, ambient scribes — which listen in to the audio of a visit and turn it into a structured clinical note for the electronic health record — are leading the pack. And to find the right scribe at the right price, health systems are pitting them against each other.
CMS, HHS can use existing federal authority to regulate AI safety in hospitals: JAMA
Fierce Healthcare
JULY 30, 2024
As artificial intelligence rapidly makes inroads in healthcare, federal agencies already have the authority to regulator AI at the hospital bedside, according to some healthcare researche | An article published in JAMA Health Forum argues that through the conditions of participation in Medicare and Medicaid, CMS has the authority to oversee how hospitals are implementing AI into patient care.
STAT+: NIH loses suit over censoring social media comments made by animal rights advocates
STAT
JULY 30, 2024
In a boost for animal rights advocates, a U.S. appeals court ruled that a National Institutes of Health policy for monitoring comments posted to its online forums violated the First Amendment because the agency made a point of removing remarks about animal testing. At issue was an effort by the NIH to exclude “off-topic” discussions about its work.
Community Pharmacy Managers, Owners Must Address Workplace Violence
Pharmacy Times
JULY 30, 2024
Although important for patient health care, pharmacies’ convenient locations leave staff prone to workplace violence.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Opinion: How artificial intelligence can bolster Europe’s competitive edge in biopharma
STAT
JULY 30, 2024
In a year marked by European Parliament elections and setting of the European Union’s priorities for the next five years, it’s time for the EU to make innovation in health and biopharmaceuticals a strategic priority for the region’s resilience and security. Europe is currently facing a competitiveness crisis. EU productivity has declined 1.2% in the fourth quarter of 2023 compared to the previous year, while U.S. productivity rose 2.6%.
Pharmacy Focus - Oncology Edition: The Link Between Gut Health and Colon Cancer, Exploring the Wellness Innovation Network
Pharmacy Times
JULY 30, 2024
Jennifer Dunphy, DrPH, MBA, MPH and Nelly Awkar-Lazo, MD, discuss the rise in young-onset cancer, the gut-colon cancer link, and the importance of healthy lifestyle choices for cancer prevention.
Substance use stayed at high levels in 2023, while vaping increased and smoking fell
STAT
JULY 30, 2024
Rates of mental illness and substance use remained largely stable in 2023, according to federal data, underscoring the severity of the long-running U.S. mental health crisis and worst-in-the-world rates of illicit drug use. And while overall rates of nicotine use also remained roughly even, the way people consumed it shifted slightly. Overall, slightly more Americans vaped nicotine, while slightly fewer smoked cigarettes.
Five Fast Facts About IVIG
Pharmacy Times
JULY 30, 2024
By functioning as an antibody replacement therapy, IVIG can be used to manage a wide range of inflammatory and autoimmune disorders.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Wells Fargo faces class action lawsuit over workers’ high drug costs
STAT
JULY 30, 2024
Former employees sued Wells Fargo on Tuesday, alleging the banking giant violated federal law by not diligently monitoring how much it was paying for their prescription drugs, which led to massive overcharges. The class action lawsuit is the second of its kind filed in federal court, further heightening the legal risks for employers that don’t scrutinize how they purchase health and drug benefits for their workers.
How the feds should handle rampant insurer upcoding
Fierce Healthcare
JULY 30, 2024
Enforcement and physician education are two keys to limiting health plan upcoding, a costly scheme that exploits the Medicare system, health policy experts told Fierce Healthcare. | Health plan upcoding threatens the Medicare system. Here's how policy experts believe the federal government should pursue abuse.
STAT+: Eisai, Biogen make case for long-term use of Alzheimer’s drug Leqembi with new data
STAT
JULY 30, 2024
Patients with early Alzheimer’s disease treated with a medication developed by Eisai and Biogen for up to three years experienced less cognitive decline than what’s expected of untreated patients based on historical data, according to new study results reported Tuesday. The manufacturers said the data support long-term, continuous use of the drug.
Tezepelumab Reduces Exacerbations in Patients With Severe, Uncontrolled Asthma
Pharmacy Times
JULY 30, 2024
Compared with placebo, tezepelumab reduced the annual asthma exacerbation rate in multiple subpopulations and asthma-related comorbidities.
STAT+: Merck shares fall as sales of HPV vaccine drop in China
STAT
JULY 30, 2024
Shares of Merck fell 9% Tuesday after the company reported that in the second quarter, it saw a decrease in shipments of its HPV vaccine Gardasil in China, a significant market for the drug. The company brought in $2.48 billion in sales of Gardasil in the second quarter, slightly lower than estimates of $2.5 billion made by analysts polled by Visible Alpha.
Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive
Fierce Pharma
JULY 30, 2024
For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. | For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. And while the busy has been busy trimming operating expenses, it did add $1 billion to its total revenue projection for the year.
U.S. indicts North Korean hacker for leading ransomware attacks against hospitals
Fierce Healthcare
JULY 30, 2024
A federal grand jury indicted a North Korean national for allegedly leading ransomware attacks in 2022 against U.S. hospitals. | A federal grand jury indicted a North Korean national for allegedly leading ransomware attacks against U.S. hospitals. The government is offering a reward of up to $10 million for information on the hacker and other cybercriminals targeting critical infrastructure.
A symbiotic relationship for optimal AI-powered healthcare
pharmaphorum
JULY 30, 2024
Discover how OPEN Health and fusion's AI technology partnership is creating a symbiotic relationship that is revolutionising healthcare. Explore the benefits of this for optimal patient care.
Testing GLP-1s in Alzheimer’s, and is Medicare a good negotiator?
STAT
JULY 30, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. If anything will motivate me to get through this week, it’s knowing that Simone Biles went on to nail the most difficult vault even while experiencing calf problems. That and also everyone’s new obsession over pommel horse king Stephen Nedoroscik.
Physicians say GLP-1s are imperfect, not “silver bullet” to solve obesity crisis
Fierce Healthcare
JULY 30, 2024
As GLP-1s have risen in popularity, physicians have been the subject of blame and criticized for being too quick to prescribe these weight loss medications. | Newly released survey data show doctors do not believe GLP-1s are sustainable beyond 2-3 years, given side effects, results and costs.
Eco HPLC-based method shows promise for Z-alkene synthesis
European Pharmaceutical Review
JULY 30, 2024
Japanese researchers have developed a new method for photoisomerisation of E -cinnamamides to Z -cinnamamides. The approach uses a recycling photoreactor coupled with a high-performance liquid chromatography (HPLC) system. As organic compounds, many Z -alkenes “cannot be prepared through conventional methods involving thermodynamic methods”. On the other hand, “photoisomerisation can offer good yields”, they noted.
5 cybersecurity guidelines for remote monitoring in clinical trials
pharmaphorum
JULY 30, 2024
Implementing strong cybersecurity guidelines for remote monitoring in clinical trials is crucial to protect sensitive data. Learn these top 5 guidelines to secure your remote monitoring plan effectively.
Zing Health, Story Health team up for value-based cardiovascular program
Fierce Healthcare
JULY 30, 2024
Medicare Advantage insurer Zing Health has tapped Story Health for a new partnership aimed at offering more personalized care for patients with cardiovascular needs. | Medicare Advantage insurer Zing Health has tapped Story Health for a new partnership aimed at offering more personalized care for patients with cardiovascular needs.
Slideshow: Vitamin D, Platelet-Rich Plasma for Treatment of Dry Eye Disease
Drug Topics
JULY 30, 2024
Recent studies on dry eye disease examined the efficacy of Vitamin D, platelet-rich plasma as a treatment option, and associations with certain systemic medications.
Approaching the regulatory world with passion: CERs and EU MDR processes
pharmaphorum
JULY 30, 2024
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ethan Drower, co-founder and CEO of Cite Medical Solutions, a company providing full Clinical Evaluation Report (CER) services and industry literature review for European Union Medical Device Regulation (or EU MDR) processes.
Let's personalize your content